TABR Capital Management »

Alnylam Pharmaceuticals shares owned by TABR Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by TABR Capital Management from 13F filings

Historical chart of TABR Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by TABR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by TABR Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $226k 504 447.49

More positions owned by TABR Capital Management

Ishares Tr Ibonds Dec2026 (IBDR)
Ishares Tr Ibonds 27 Etf (IBDS)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Ishares Tr Micro-cap Etf (IWC)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Rus Mid Cap Etf (IWR)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Ibonds Dec25 Etf (IBDQ)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for TABR Capital Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals